Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients — Sarah Essilfie-Quaye (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients
Shared by
Peter J Barnes
Imperial College London
Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients
Article
2011
en
Authors
+2 more
SE
Sarah Essilfie-Quaye
KI
Kazuhiro Ito
MI
Misako Ito
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2011
Supplementary material : Comparison of Symbicort ® versus Pulmicort ® on steroid pharmacodynamic markers in asthma patients
Sarah Essilfie-Quaye
,
Kazuhiro Ito
,
Misako Ito
,
Sergei A. Kharitonov
,
Peter J Barnes
Article
1998
An inhaled steroid improves markers of airway inflammation in patients with mild asthma
Anon Jatakanon
,
Sai Kiang Lim
,
Kian Fan Chung
,
Peter J Barnes
Article
1995
Steroid resistance in asthma
Peter J Barnes
,
Ian M. Adcock
Article
2000
Altered steroid binding in PBMC corellates strongly with steroid in-sensitivity in patients with difficult asthma
J.G. Matthews
,
E M Irusen
,
S. Smith
,
Rob G. Stirling
,
Donald Campbell
,
David S. Robinson
,
Kian Fan Chung
,
Peter J Barnes
,
Ian M. Adcock
Article
1994
Comparison of Adrenocorticotropin and Adrenal Steroid Responses to Corticotropin-Releasing Hormone Versus Metyrapone Testing in Patients with Hypopituitarism
Linda Riddick
,
George Chrousos
,
Susan Jeffries
,
Songya Pang
Discussion(0)
No comments yet. Be the first to comment.